Mark Curran
About Mark Curran
Mark Curran is the Director of Biomarker Biology and previously held the same position at Bristol-Myers Squibb.
Title
Mark Curran holds the position of Director, Biomarker Biology. In this role, he is responsible for overseeing efforts related to the identification and validation of biomarkers, which are critical for understanding disease mechanisms and developing targeted therapies.
Previous Experience at Bristol-Myers Squibb
Mark Curran previously worked as the Director of Biomarker Biology at Bristol-Myers Squibb. His tenure at this leading biopharmaceutical company involved significant contributions to biomarker research, which supports the development of innovative therapeutics aimed at addressing unmet medical needs.
Education and Expertise
Mark Curran studied at the University of Utah School of Medicine from 1989 to 2005, totaling 16 years. This extensive period of study provided him with a deep knowledge base and expertise in medical and biological sciences, grounding his career in biomarker biology and research.